Endocrinology Vol. 138, No. 9 3997-4004
Copyright © 1997 by The Endocrine Society
Glucose Transporter GLUT3 in the Rat Placental Barrier: A Possible Machinery for the Transplacental Transfer of Glucose
Bo-Chul Shin,
Keiko Fujikura,
Takeshi Suzuki,
Shigeyasu Tanaka and
Kuniaki Takata
Laboratory of Molecular and Cellular Morphology, Department of Cell
Biology, Institute for Molecular and Cellular Regulation, Gunma
University, Maebashi, Gunma 371, Japan
Address all correspondence and requests for reprints to: Kuniaki Takata, Ph.D., Laboratory of Molecular and Cellular Morphology, Department of Cell Biology, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma 371, Japan.
 |
Abstract
|
|---|
Glucose transfer across the placental barrier is crucial for fetal
development. To investigate the role of glucose transporter isoforms in
the transplacental transfer of glucose, we investigated the
localization of glucose transporters GLUT1 and GLUT3
immunohistochemically in the rat placenta. In the labyrinth, the site
of maternofetal exchange of substances, both GLUT1 and GLUT3 were
present, whereas only GLUT1 was detected in the junctional region. In
the labyrinthine wall, which lies between maternal and fetal
circulations, GLUT3 exhibited polarized localization; i.e.
it was present at the plasma membranes of the maternal blood side in
the syncytiotrophoblast layers. GLUT1 was concentrated at plasma
membranes of the maternal and fetal blood sides of syncytiotrophoblast
layers. The asymmetric distribution of GLUT3 across the placental
barrier may suggest asymmetric transfer of glucose, which would be
beneficial to provide a stable milieu for fetal development.
 |
Introduction
|
|---|
GLUCOSE is one of the major
energy sources in the mammalian body. The cellular uptake of glucose
across the plasma membrane is mediated by integral membrane proteins,
glucose transporters. Two kinds of glucose transporters have been
identified (1, 2, 3, 4, 5, 6): facilitated-diffusion glucose transporters for the
concentration-dependent transport of glucose across the membrane, and
Na+-dependent transporters for the active absorption of
glucose against the concentration gradient in the intestine and kidney
cells. Mammalian facilitated-diffusion glucose transporters, the GLUTs,
are expressed tissue specifically (2, 3, 5, 7, 8, 9, 10). GLUT1 is
concentrated at the critical plasma membranes of blood-tissue barriers
(11) such as the blood-brain barrier (12), the blood-ocular barrier
(13, 14, 15, 16), and the placental barrier (17, 18, 19, 20, 21). GLUT2, an isoform with
low affinity and high capacity, is present in liver, intestine, kidney,
and pancreatic ß-cells (22). In rodents, GLUT3 is abundant in the
brain (10, 23, 24, 25, 26) and is also expressed in the placenta (10, 25, 27, 28, 29). GLUT4 is specifically expressed in fat and muscle cells, whose
translocation by insulin from the intracellular pool plays a pivotal
role in the maintenance of the blood glucose level (30, 31, 32, 33).
Glucose is transferred from the maternal blood to the fetal circulation
across the placental barrier, which separates the maternal and fetal
circulation. In contrast to the human placenta, where numerous villi
are formed (34), a complex of maternal and fetal circulations termed
the labyrinth, develops in the rat placenta (35). The labyrinthine part
of the placenta is the principal site of maternofetal exchange of
substances. The labyrinthine wall, or interhemal membrane, which lies
between the maternal blood space and fetal vessels, is composed of
three layers of trophoblast (36, 37), i.e. the porous
cytotrophoblast layers and syncytiotrophoblast layers I and II, from
the maternal to fetal sides. We have previously shown by immunoblotting
that GLUT1 protein is abundant in the rat placenta (21, 38, 39).
In situ hybridization also confirmed the expression of GLUT1
(28). Immunohistochemical analysis revealed that GLUT1 is present in
the syncytial cell layers. Detailed examination revealed the
localization of GLUT1 at the plasma membranes of the maternal blood
side of syncytiotrophoblast I and the fetal blood side of
syncytiotrophoblast II (39). Syncytiotrophoblasts I and II are
connected by numerous gap junctions (40, 41, 42). Immunohistochemical
examination showed that these gap junctions are made of connexin 26
(Cx26), an isoform of gap junction channel proteins (16). We proposed
that GLUT1, connexin 26, and GLUT1 lined in series in the
syncytiotrophoblast layers constitute the machinery for the
transplacental transfer of glucose through the rat placental barrier
(11, 19, 21).
In addition to GLUT1, GLUT3 has been shown to be expressed in the rat
placenta; and its possible involvement in the maternofetal transfer of
glucose was suggested (28). The precise cellular localization of GLUT3
and comparison of the localization between GLUT1, GLUT3, and connexin
26, however, has not been made in the rat placental barrier. As such
information should shed light on the glucose transfer machinery in the
placental barrier, in this study we raised antibodies against rat GLUT3
and examined the localization of GLUT3 protein in the rat placental
barrier by double-immunofluorescence staining for GLUT1 and GLUT3. We
suggest a possible mechanism involving GLUT1, GLUT3, and connexin 26
for the transplacental transfer of glucose across the rat placental
barrier.
 |
Materials and Methods
|
|---|
Antibodies
Anti-GLUT1 and anti-GLUT4 antibodies were raised in guinea
pigs against the synthetic peptides corresponding to amino acids
480492 (C-terminus) and 502509 (C-terminus) of the deduced amino
acid sequences of human GLUT1 (43) and rat GLUT4 (30), respectively, by
use of keyhole limpet hemocyanin conjugates. Rabbit anti-GLUT1
antibodies raised against purified human erythrocyte glucose
transporter (44) and against human GLUT1 C-terminus peptide (39) were
also used. Anti-GLUT3 antibody was raised in a rabbit against the
synthetic peptide corresponding to amino acids 449458 (C-terminus) of
the deduced amino-acid sequence of rat GLUT3 (23, 45), basically as
described (46). In short, a rabbit received subcutaneous multiple
immunizations followed by four iv booster injections of keyhole limpet
hemocyanin-conjugated peptide antigen. Rabbit antirat GLUT2 was
purchased from East Acres Biologicals (Southbridge, MA). Anti-GLUT5
antibody was raised in the rabbit and characterized as previously
described (47).
Tissue preparations
Wistar rats at 12, 14, 16, and 18 days of pregnancy were
obtained from Imai Experimental Animal Farm (Gunma, Japan). Days of
pregnancy were designated as previously described (39). The animals
were anesthetized with sodium pentobarbital, and placentas (n =
810 from each animal) were removed, cut into pieces, and washed with
PBS to remove blood. Brain (cerebral cortex) was taken from male
4-week-old Wistar rats supplied from the Animal Breeding Facility,
Gunma University (Gunma, Japan).
Immunoblotting
The tissue specimens were homogenized in PBS containing protease
inhibitors (38). Protein content was measured by the BCA Protein Assay
Reagent (Pierce, Rockford, IL). Homogenate (10 µg of protein) was
electrophoresed through SDS polyacrylamide gels and transferred to
membrane filters (Immobilon-PSQ, Millipore, Bedford, MA). The blotted
membranes were sequentially incubated with 3% BSA, guinea pig
anti-GLUT1 or rabbit anti-GLUT3 antibodies diluted at 1:1000 each, and
125I-protein A (New England Nuclear, Wilmington, DE).
Autoradiography was performed for 0.518 h with imaging plates, and
the plates were processed with a BAS2000 bioimage analyzer (Fuji Film,
Tokyo, Japan).
Light-microscopic immunohistochemistry
Specimens were fixed in 4% formaldehyde in 0.1
M sodium phosphate buffer, pH 7.4, for 3 h at room
temperature, washed with PBS, infused in 20% sucrose in 0.1
M sodium phosphate buffer, pH 7.4, containing 0.02% sodium
azide, and embedded in OCT compound. Specimens were rapidly frozen in
liquid nitrogen, and then sectioned (6-µm thickness) with a cryostat.
Some of the fixed specimens were cut into small pieces and infused with
2.3 M sucrose in 0.1 M sodium phosphate buffer,
pH 7.4, containing 0.02% sodium azide. Infused tissue blocks were
mounted on stubs and rapidly frozen in liquid nitrogen. Semithin frozen
sections (0.51 µm thickness) were cut at -60 C with a Leica
Ultracut S UCT ultramicrotome equipped with an EM FCS cryokit (Leica,
Austria) and glass knives and collected on glass slides.
Immunofluorescence staining was carried out essentially as previously
described (16, 21, 39). For double-immunofluorescence staining for
GLUT1 and GLUT3, sections were covered with 5% normal goat serum in
PBS for 10 min and incubated for 1 h with a mixture of guinea pig
anti-GLUT1 antibody and rabbit anti-GLUT3 antibody, each diluted at
1:500 and 1:1000, respectively. After having been washed with PBS, the
sections were incubated with a mixture of DTAF (dichlorotriazinyl amino
fluorescein)-labeled donkey antiguinea pig IgG (Jackson Immunoresearch,
West Glove, PA), LRSC (lissamine rhodamine sulfonyl chloride)-labeled
donkey anti-rabbit IgG (Jackson Immunoresearch), and DAPI
(4',6-diamidino-2-phenylindole dihydrochloride, Boehringer-Mannheim,
Mannheim, Germany) for 1 h. Specimens were washed with PBS,
mounted using antibleaching mounting medium (21), and examined with a
BX-50 microscope (Olympus, Tokyo, Japan) equipped with epifluorescence
and Nomarski differential interference-contrast optics.
Electron-microscopic immunohistochemistry
Specimens were fixed in 4% formaldehyde in 0.1
M sodium phosphate buffer, pH 7.4, for 3 h at room
temperature, and washed with PBS. They were infused with 20% sucrose
in 0.1 M sodium phosphate buffer, pH 7.4, containing 0.02%
sodium azide, embedded in OCT compound (Miles, Elkhart, IN), and
rapidly frozen in liquid nitrogen. Cryostat sections (10-µm
thickness) were cut and mounted on glass slides coated with
poly-L-lysine. The sections were covered with 5% normal
goat serum in PBS for 10 min and incubated for 1 h at room
temperature with rabbit anti-GLUT3 antibody diluted at 1:1000. After a
rinse with PBS, sections were incubated for 1 h at room
temperature with 1.4-nm gold particles conjugated to Fab' fragments of
antirabbit IgG (Nanogold, Nanoprobes, Stony Brook, NY), diluted at 1:50
(48). After a rinse with PBS, the sections were refixed with 1%
glutaraldehyde for 30 min. The labeled sections were next washed for 30
min with six changes of PBS and incubated with silver enhancement
solution containing 1 mg/ml silver acetate, 14 mg/ml trisodium citrate
dihydrate, 15 mg/ml citric acid monohydrate, and 2.5 mg/ml
hydroquinone, for 315 min at room temperature (49). After two quick
rinses with distilled water, the specimens were immersed in 0.05%
sodium acetate for 1 min, and then, after a rinse for 30 min in six
changes of water, were treated with 0.05% chloroauric acid for 2 min
at room temperature. After another rinse for 30 min in six changes of
water, the sections were fixed with 1% osmium tetroxide in 0.1
M sodium phosphate buffer, pH 7.4, for 30 min, dehydrated
through a series of graded ethanols, and embedded in epoxy resin.
Ultrathin sections were cut, stained with uranyl acetate and lead
citrate, and examined with a JEM-1010 transmission electron microscope
(JEOL, Tokyo, Japan).
Immunohistochemical controls
Sections were incubated with normal serum instead of the primary
antibody. The specificity was also checked by incubation with the
primary antibody in the presence of the peptides (5 µg/ml) used to
generate the antibody. These immunohistochemical controls were carried
out side by side with the experimental slides for both
immunofluorescence and immunoelectron microscopic
immunohistochemistry.
 |
Results
|
|---|
Immunoblotting
By using the rabbit antirat GLUT3 antibody, we detected a 45-kDa
protein in rat brain cerebral cortex homogenate (Fig. 1a
). In the 18-day placenta homogenate, a
40-kDa protein was detected, showing the presence of the GLUT3 glucose
transporter in the rat placenta (Fig. 1b
). A 42-kDa protein was
detected in the homogenate of the 18-day placenta with the guinea pig
anti-GLUT1 (Fig. 1c
), which confirmed our previous results (21).

View larger version (35K):
[in this window]
[in a new window]
|
Figure 1. Immunoblotting analysis of the rat placenta with
antibodies against GLUT1 and GLUT3. Brain and 18-day placenta
homogenates (10 µg protein each) were subjected to SDS-PAGE. The
brain specimen was immunoblotted with rabbit anti-GLUT3 antibody (a),
and placenta specimens with rabbit anti-GLUT3 (b) or guinea pig
anti-GLUT1 antibody (c).
|
|
Immunofluorescence localization of GLUT3 and GLUT1
Development of the labyrinth of the rat placenta begins
around day 12 (35). Although the labyrinth occupies only a small
portion of the placenta at first, it becomes a major part of the
placenta in day 18. Labyrinth and junctional zone were easily
distinguished by nuclear DNA staining as previously described (29). In
the rat placental labyrinth, the maternal blood space and fetal blood
vessels were distinguished according to the criteria described
previously (21, 39, 41). In short, the maternal blood space faces the
large nuclei of the cytotrophoblast, whereas the fetal blood vessels
are lined with smaller nuclei of endothelial cells.
Localization of GLUT3 and GLUT1 was carried out by immunofluorescence
staining of cryostat (Fig. 2
) and
semithin frozen sections (Fig. 3
) of rat
placentas. We examined the localization of GLUT1 and GLUT3 on days 12,
14, 16, and 18. On day 12, both GLUT3 and GLUT1 were detected in the
labyrinth, whereas only GLUT1 labeling, although weak, was detected in
the junctional zone (Fig. 2
, af). GLUT3 staining was restricted to
the labyrinth. On day 18, both GLUT3 and GLUT1 were present in the
labyrinth, where maternofetal exchange of substances occurs (Fig. 2
, gi). In the junctional zone, strong labeling for GLUT1 was detected
(Fig. 2h
), but no labeling for GLUT3 (Fig. 2g
).

View larger version (156K):
[in this window]
[in a new window]
|
Figure 2. Immunofluorescence localization of GLUT3 and GLUT1
in 12-day (af) and 18-day (gi) rat placentas. Cryostat sections
were doubly stained for GLUT3 with LRSC-label (a, g) and for GLUT1 with
DTAF-label (b, h). Corresponding Nomarski-differential
interference-contrast image (i) is shown. Immunohistochemical controls
in 12-day placenta (cf) are also shown. La, Labyrinthine region; Ju,
junctional region. Bar, 100 µm. a and b, In the
labyrinth, both GLUT3 and GLUT1 are present, whereas only weak labeling
for GLUT1 is seen in the junctional region. cf, In the
immunohistochemical controls, no positive staining is seen with either
normal rabbit serum (c), or normal guinea pig serum (e). To identify
labyrinthine and junctional regions, corresponding nuclear DNA images
with DAPI (d, f) are shown. gi, Localization of GLUT3 is restricted
to the labyrinth as well (g), whereas GLUT1 is present in both the
junctional and labyrinthine regions (h).
|
|

View larger version (109K):
[in this window]
[in a new window]
|
Figure 3. Immunofluorescence localization of GLUT3 and GLUT1
in the labyrinth in semithin-frozen sections. Sections were stained for
GLUT3 with LRSC-label (red), and for GLUT1 with DTAF-label
(green). Nuclei were counterstained with DAPI
(blue). Regions of overlap of red and
green fluorescence appear yellow on double
exposures. Images for GLUT3 (a, d, g), and GLUT1 (b, e, h), as well as
double-exposure images for
both (c, f, i), are shown. Corresponding
Nomarski-differential interference-contrast image (j) is also shown. M,
Maternal blood space; F, fetal blood vessel; Cy, cytotrophoblast; *,
undifferentiated cells. Bars, 10 µm. ac, Labyrinth
of 12-day placenta. a, GLUT3 (red) is seen as two
lines between the maternal and fetal circulations (double
arrowheads, arrowheads) in the labyrinth. b, GLUT1
(green) is seen as three lines (double arrowheads,
arrowheads, and arrows). GLUT1 is also present in
undifferentiated cells (*). c, A double-exposure image shows three
distinct lines of various width: the first one (double
arrowheads) along the maternal blood space, the second one
(arrowheads) between syncytiotrophoblastic layers I and II,
and the third one (arrows) facing the fetal blood vessel or
undifferentiated cells. Note that GLUT3 and GLUT1 are colocalized in
the first and second lines, whereas only GLUT1 is seen in the
innermost, third line. df, Labyrinth of 14-day placenta. d, GLUT3
(red) is seen as two lines between maternal and fetal
circulations (double arrowhead, arrowhead). e, GLUT1
(green) is also seen as two lines
(double arrowhead, arrow). f, A double-exposure image shows
three distinct lines similar to those in 18-day placenta (double
arrowhead, arrowhead, arrow). gi, Labyrinth of 18-day placenta.
g, GLUT3 (red) is seen as two lines between
maternal and fetal circulations (double arrowhead,
arrowhead). h, GLUT1 (green) is also seen as two
lines but with a wider space (double arrowhead,
arrow). i, A double-exposure image shows three distinct
lines. The first one, closest to the maternal blood, is
positive for both GLUT3 and GLUT1 (double arrowhead,
yellow). The middle one, lying between syncytiotrophoblast layers
I and II, is positive for GLUT3 (arrowhead, red). The
innermost one, next to a fetal capillary (F), is positive for GLUT1
(arrow, green). Positive staining for GLUT3 or GLUT1 was not
seen in cytotrophoblast or endothelial cells of fetal blood vessels in
the 12-, 14-, or 18-day placenta.
|
|
To further analyze the localization of GLUT1 and GLUT3 in the
labyrinthine wall, we examined semithin frozen sections (Fig. 3
). On
day 12, three GLUT1-positive lines were evident in the
syncytiotrophoblast layers located between the maternal blood space and
fetal capillaries in the labyrinth (Fig. 3b
). In addition to
syncytiotrophoblast layers, nonsyncytial undifferentiated cells located
beneath the syncytial cells were positive for GLUT1 (Fig. 3b
). GLUT3
labeling in the syncytial cell layer formed two positive lines between
the maternal blood space and fetal capillaries (Fig. 3a
). Nonsyncytial
undifferentiated cells were negative or weak for GLUT3 labeling.
Double-exposure images showed three lines along syncytiotrophoblast
layers: yellow, yellow, and green from the
maternal side (Fig. 3c
), showing the coexistence of GLUT3 and GLUT1 in
the maternal side of syncytiotrophoblast I and between
syncytiotrophoblast layers I and II. The basal side of
syncytiotrophoblast II was positive for GLUT1 only (Fig. 3c
). Neither
GLUT3 nor GLUT1 was detected in cytotrophoblasts directly facing the
maternal blood in the labyrinth (Fig. 3
, ac). Localization pattern of
GLUT3 and GLUT1 in the labyrinthine wall began to change on day 14
where decrease of GLUT1 labeling in between syncytiotrophoblast layers
I and II was evident (Fig. 3
, df). On days 16 and 18, the labyrinth
was occupied with typical placental labyrinthine structure with a
single cytotrophoblast layer, two syncytial layers, and fetal
endothelium. Undifferentiated trophoblasts were rarely encountered.
GLUT1 exhibited two distinct lines along the double syncytiotrophoblast
layers separating the maternal blood space and fetal blood vessels
(Fig. 3h
). Positive staining for GLUT1 was not seen in cytotrophoblast
or endothelial cells of fetal blood vessels. GLUT3 was localized along
double syncytial layers facing the maternal blood space and between the
double syncytial layers, forming two distinct lines (Fig. 3g
). Positive
staining for GLUT3 was not seen in cytotrophoblast or endothelial cells
of fetal blood vessels, either. Double-exposure images clearly showed
that GLUT3 and GLUT1 were colocalized in syncytiotrophoblastic layer I
along the cell contour facing the maternal blood space (Fig. 3i
).
Between double syncytial layers in the interhemal membrane, only GLUT3
was detected. Only GLUT1 was present along the cell contour of
syncytiotrophoblast layer II facing the fetal blood vessels. Three
anti-GLUT1 antibodies, two of them raised in rabbits and one in a
guinea pig, gave the same staining pattern (data not shown). Other
glucose transporter isoforms tested, i.e. GLUT2, GLUT4, and
GLUT5, showed no positive staining in the labyrinth (data not
shown).
Ultrastructural localization of GLUT3 in 18-day placenta
To examine the ultrastructural localization of GLUT3, we used
Nanogold probes to carry out preembedding electron-microscopic
immunohistochemistry on the 18-day placenta. In the labyrinth, GLUT3
was localized at the plasma membrane of syncytiotrophoblast I facing
the maternal blood space (Fig. 4
, a and
b). It was also present at the plasma
membrane of the syncytiotrophoblast II facing syncytiotrophoblast I
(Fig. 4
, c and d). The basal side of syncytiotrophoblast II and the
plasma membrane of syncytiotrophoblast I facing syncytiotrophoblast II
were negative for GLUT3.

View larger version (178K):
[in this window]
[in a new window]
|
Figure 4. Ultrastructural localization of GLUT3 in 18-day
rat placental labyrinth by the immunogold-labeling method. M, Maternal
blood space; F, fetal capillary; Cyt, cytotrophoblast; End, endothelial
cell of a fetal capillary. a, A survey view of the
labyrinthine wall. Positive staining for GLUT3 is seen in the membrane
of syncytiotrophoblast layer I (Syn I) facing the maternal blood side
(arrowheads). GLUT3 is also present in between
syncytiotrophoblast layers I and II (Syn II) (arrows).
Positive staining for GLUT3 is not seen in cytotrophoblast or
endothelial cells of fetal blood vessels. Bar, 1 µm.
b, GLUT3 is seen along the plasma membrane of syncytiotrophoblast
layers I (Syn I) facing the cytotrophoblast (arrowheads).
Bar, 0.5 µm. c and d, GLUT3 is localized at the plasma
membrane (arrows) of syncytiotrophoblast layer II (Syn II).
Bar, 0.5 µm.
|
|
Immunohistochemical controls
When the primary antibody was replaced with normal serum (Fig. 2
, cf) or a mixture of the primary antibody and 5 µg/ml antigen
peptide, no positive labeling was seen in either immunofluorescence or
immunogold studies (data not shown). In the double-immunofluorescence
studies, replacement of one of the primary antibodies with normal serum
did not affect the staining with the other antibody. These control
experiments confirmed the specificity of the immunostaining.
 |
Discussion
|
|---|
The rat placenta is divided into two parts, the junctional zone
and the labyrinthine zone. Maternofetal exchange of substances
including glucose occurs in the labyrinth. By immunoblotting and
immunohistochemistry, we have demonstrated here the presence and
localization of glucose transporter isoforms GLUT3 and GLUT1 in the rat
placenta. The double-immunofluorescence studies clearly showed the
location of GLUT1 and GLUT3 in the mature placenta: both GLUT1 and
GLUT3 were present in the labyrinthine region, whereas only GLUT1 was
found in the junctional region. In the labyrinth, or the interhemal
membrane, we localized GLUT1 and GLUT3 precisely in
syncytiotrophoblasts: colocalization of GLUT1 and GLUT3 at the plasma
membrane facing the maternal blood side, GLUT1 at the membrane of
syncytiotrophoblast II facing fetal blood vessels, and GLUT3 at the
membrane of syncytiotrophoblast II adjacent to syncytiotrophoblast I.
These findings suggest that GLUT1 and GLUT3 may serve in concert for
the maternofetal transfer of glucose.
Expression of GLUT1 alone in the junctional region, but expression of
both GLUT1 and GLUT3 in the labyrinthine part, was reported earlier
(28, 29), and our findings (Fig. 2
) are consistent with their results.
Because GLUT1 is ubiquitous in the placenta, it was suggested that
GLUT1 may be responsible for supplying glucose for use as a placental
fuel (28). Specific expression of GLUT3 in the labyrinth, which is
specialized in nutrient transfer, suggested that GLUT3 may be important
for the maternofetal transfer of glucose (28). GLUT3, having a
relatively lower Km value (10, 50) compared with that of
GLUT1, may confer effective transfer of glucose into the
syncytiotrophoblast in the case of hypoglycemia in a similar manner as
in neurons and also serve for retention of the sugar in the
syncytiotrophoblast as a reservoir. In fact, deposition of glycogen in
the syncytiotrophoblast layers was reported by electron microscopy (37, 41). Because detailed examination of the localization of GLUT1 and
GLUT3 in the labyrinthine wall would provide evidence to determine the
validity of this notion, we carried out high resolution
immunofluorescence and immunoelectron microscopic studies. We found
that both GLUT3 and GLUT1 were localized at the plasma membrane of the
syncytiotrophoblast I facing the maternal blood side, a site of entry
into the syncytial layers from the maternal blood side. Both GLUT3 and
GLUT1, especially GLUT3 with its higher affinity for glucose, should
play an important role for the entry of glucose into the syncytial cell
layers. Only GLUT1 was detected at the plasma membrane of
syncytiotrophoblast II facing the fetal blood side, the site of exit
from the syncytial cell layers to the fetal blood side. Therefore,
GLUT3 could not be directly involved in the efflux into the fetal blood
side from the syncytiotrophoblast layers, the site of the placental
barrier. Instead, GLUT1 should play a prime role for the exit of
glucose from the syncytial layers. In addition to GLUT1 and GLUT3,
abundant connexin 26 is present between the two syncytiotrophoblast
layers connected by gap junctions (21). Taking into account the
ultrastructure of the placental labyrinth (35, 40, 41, 42) and the
localization of GLUT3, GLUT1 (39), and connexin 26 (21), we suggest
that transfer of glucose across the placental barrier occurs as
follows: glucose freely passes the cytotrophoblast layer through pores
in it. GLUT3 and GLUT1 in the syncytiotrophoblast I are responsible for
the uptake of glucose into its cytoplasm. Glucose is then transferred
to the cytoplasm of the syncytiotrophoblast II via connexin 26 channels
of gap junctions between the two syncytial cell layers. Glucose leaves
the syncytiotrophoblast II via GLUT1, and enters the fetal circulation
by crossing the endothelial cell through numerous fenestrations. The
function of GLUT3 at the plasma membrane of syncytiotrophoblast II
facing syncytiotrophoblast I remains to be clarified. It may possibly
serve to retrieve glucose that somehow managed to pass the
syncytiotrophoblast I, the first barrier cell layer.
In the placentas of diabetic rats, placental GLUT3 messenger RNA and
protein increased, whereas those of GLUT1 remained unchanged (29). A
similar increase in GLUT3 was also observed in rats with short-term
hyperglycemia achieved by hyperglycemic clamps (29). GLUT3 in the rat
placenta, therefore, appears to be highly sensitive to the blood
glucose level and to play an important role in the alteration of
placental function in the diabetic placenta (29). These results are
basically in accord with our model of glucose transfer, that GLUT1
localized at the site of entry and exit in the placental barrier may
ensure a basal transfer of maternofetal glucose transfer. Asymmetric
distribution of GLUT3 in the syncytiotrophoblast layers may suggest
asymmetric kinetics of glucose transfer across the placental barrier.
Presence of both GLUT1 and GLUT3 at the site of entry into and of GLUT1
at the site of exit from the barrier would confer the retention of
glucose in the fetus and would be beneficial to provide a stable milieu
for the fetal development. In hyperglycemia, increases in GLUT3 and
glycogen were observed (29), suggesting that overflowed glucose can be
transferred and stored as glycogen in syncytiotrophoblasts within
placenta through GLUT3 facing the maternal side. Upon maternal
hypoglycemia, stored placental sugars may be transferred to the fetal
blood circulation through GLUT1 facing the fetal side for fetal
development, which transfer would prevent a large fluctuation of the
glucose level in the fetal blood. Syncytiotrophoblasts therefore could
serve not only as a transfer machinery, but also as a reservoir of
nutrients. GLUT3, with its high affinity for glucose, localized at the
membrane of syncytiotrophoblast I facing the maternal blood sides,
may ensure the influx of glucose into syncytiotrophoblast I under the
condition of maternal hypoglycemia.
In the ciliary body epithelium, double-epithelial cell layers composed
of pigmented and nonpigmented epithelial cells serve as the structural
basis for the blood-aqueous barrier (14, 38, 51). GLUT1 is abundant at
the plasma membrane of pigmented cells facing blood vessels and of
nonpigmented cells facing the aqueous humor (14, 16). Numerous gap
junctions composed of connexin 43 (Cx43) connect the double epithelial
cell layers (16). In the rat placenta, where the barrier is also made
of double cell layers, abundant gap junctions of connexin 26 connect
these double cell layers (21). Connexins, connecting these two layers,
can serve as nonspecific hydrophilic channels for relatively small
molecules such as glucose. We suggested earlier that the combined
action of GLUT1, connexin(s), and GLUT1 in series may serve as the
machinery for the transfer of glucose across these blood-tissue
barriers (16, 21, 39). The asymmetrical presence of GLUT3 in the rat
placental barrier could be important for the efficient transfer of
glucose while preventing the loss of glucose at the time of maternal
hypoglycemia, thereby providing a stable milieu for the developing
fetus.
 |
Acknowledgments
|
|---|
We wish to thank Ms. S. Tsukui for secretarial assistance.
Received March 12, 1997.
 |
References
|
|---|
-
Bell GI, Kayano T, Buse JB, Burant CF, Takeda J,
Lin D, Fukumoto H, Seino S 1990 Molecular biology of mammalian
glucose transporters. Diabetes Care 13:198208[Abstract]
-
Bell GI, Burant CF, Takeda J, Gould GW 1993 Structure and function of mammalian facilitative sugar transporters.
J Biol Chem 268:1916119164[Free Full Text]
-
Takata K, Kasahara M, Oka Y, Hirano H 1993 Mammalian sugar transporters: their localization and link to cellular
functions. Acta Histochem Cytochem 26:165178
-
Silverman M 1991 Structure and function of hexose
transporters. Annu Rev Biochem 60:757794[CrossRef][Medline]
-
Mueckler M 1994 Facilitative glucose transporters.
Eur J Biochem 219:713725[Medline]
-
Wright EM 1993 The intestinal Na+/glucose
cotransporter. Annu Rev Physiol 55:575589[CrossRef][Medline]
-
Harik SI, Kalaria RN, Andersson L, Lundahl P, Perry
G 1990 Immunocytochemical localization of the erythroid glucose
transporter: abundance in tissues with barrier functions. J
Neurosci 10:38623872[Abstract]
-
Thomas HM, Brant AM, Colville CA, Seatter MJ, Gould
GW 1992 Tissue-specific expression of facilitative glucose
transporters: a rationale. Biochem Soc Trans 20:538542[Medline]
-
Baldwin SA 1993 Mammalian passive glucose
transporters: members of an ubiquitous family of active and passive
transport proteins. Biochim Biophys Acta 1154:1749[Medline]
-
Gould GW, Holman GD 1993 The glucose transporter
family: structure, function and tissue-specific expression. Biochem J 295:329341
-
Takata K, Hirano H, Kasahara M 1997 Transport of
glucose across the blood-tissue barriers. Intl Rev Cytol 172:153
-
Kalaria RN, Gravina SA, Schmidley JW, Perry G, Harik
SI 1988 The glucose transporter of the human brain and blood-brain
barrier. Ann Neurol 24:757764[CrossRef][Medline]
-
Harik SI, Kalaria RN, Whitney PM, Andersson L, Lundahl
P, Ledbetter SR, Perry G 1990 Glucose transporters are abundant in
cells with "occluding" junctions at the blood-eye barriers. Proc
Natl Acad Sci USA 87:42614264[Abstract/Free Full Text]
-
Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H 1991 Ultracytochemical localization of the erythrocyte/HepG2-type
glucose transporter (GLUT1) in the ciliary body and iris of the rat
eye. Invest Ophthalmol Vis Sci 32:16591666[Abstract/Free Full Text]
-
Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H 1992 Ultracytochemical localization of the erythrocyte/HepG2-type
glucose transporter (GLUT1) in cells of the blood-retinal barrier in
the rat. Invest Ophthalmol Vis Sci 33:377383[Abstract/Free Full Text]
-
Shin B-C, Suzuki T, Tanaka S, Kuraoka A, Shibata Y,
Takata K 1996 Connexin 43 and Glucose transporter GLUT1 in the
ciliary body of the rat. Histochem Cell Biol 106:209214[Medline]
-
Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H 1992 Localization of erythrocyte/HepG2-type glucose transporter (GLUT1)
in human placental villi. Cell Tissue Res 267:407412[CrossRef][Medline]
-
Takata K, Kasahara T, Kasahara M, Hirano H 1993 Glucose transporter GLUT1 in the placental barrier. In: Nakayama T,
Makino T (eds) Fourth Lake Shirakaba Placenta Conference. Keiseisha,
Tokyo, pp 5460
-
Takata K 1994 Structural basis of glucose transport
in the placental barrier: role of GLUT1 and the gap junction. Endocrine
J 41:S3S8
-
Hahn T, Hartmann M, Blaschitz A, Skofitsch G, Graf R,
Dohr G, Desoye G 1995 Localization of the high affinity
facilitative glucose transporter protein GLUT1 in the placenta of
human, marmoset monkey (Callithrix jacchus) and rat at
different developmental stages. Cell Tissue Res 280:4957[Medline]
-
Shin B-C, Suzuki T, Matsuzaki T, Tanaka S, Kuraoka A,
Shibata Y, Takata K 1996 Immunolocalization of GLUT1 and connexin
26 in the rat placenta. Cell Tissue Res 285:8389[CrossRef][Medline]
-
Thorens B 1992 Molecular and cellular physiology of
GLUT-2, a high-Km facilitated diffusion glucose transporter. Intl Rev
Cytol 137A:209238
-
Nagamatsu S, Kornhauser JM, Burant CF, Seino S, Mayo KE,
Bell GI 1992 Glucose transporter expression in brain. J Biol
Chem 267:467472[Abstract/Free Full Text]
-
Mantych GJ, James DE, Chung HD, Devaskar SU 1992 Cellular localization and characterization of Glut3 glucose transporter
isoform in human brain. Endocrinology 131:12701278[Abstract]
-
Haber RS, Weinstein SP, OBoyle E, Morgello S 1993 Tissue distribution of the human GLUT3 glucose transporter.
Endocrinology 132:25382543[Abstract]
-
Gerhart DZ, Leino RL, Borson ND, Taylor WE, Gronlund KM,
McCall AL, Drewes LR 1995 Localization of glucose transporter
GLUT3 in brain: comparison of rodent and dog using species-specific
carboxyl-terminal antisera. Neuroscience 66:237246[CrossRef][Medline]
-
Shepherd PR, Gould GW, Colville CA, McCoid SC, Gibbs EM,
Kahn BB 1992 Distribution of GLUT3 glucose transporter protein in
human tissues. Biochem Biophys Res Commun 188:149154[CrossRef][Medline]
-
Zhou J, Bondy CA 1993 Placental glucose transporter
gene expression and metabolism in the rat. J Clin Invest 91:845852
-
Boileau P, Mrejen C, Girard J, Hauguel-de Mouzon S 1995 Overexpression of GLUT3 placental glucose transporter in diabetic
rats. J Clin Invest 96:309317
-
James DE, Strube M, Mueckler M 1989 Molecular
cloning and characterization of an insulin-regulatable glucose
transporter. Nature 338:8387[CrossRef][Medline]
-
Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard
GE 1991 Translocation of the glucose transporter GLUT4 in cardiac
myocytes of the rat. Proc Natl Acad Sci USA 88:78157819[Abstract/Free Full Text]
-
Slot JW, Geuze HJ, Gigengack S, Lienhard GE, James
DE 1991 Immuno-localization of the insulin regulatable glucose
transporter in brown adipose tissue of the rat. J Cell Biol 113:123135[Abstract/Free Full Text]
-
Birnbaum MJ 1992 The insulin-sensitive glucose
transporter. Intl Rev Cytol 137A:239297
-
Castellucci M, Kaufmann P 1995 Basic structure of
the villous trees. In: Benirschke K, Kaufmann P (eds) Pathology of the
human placenta, ed 3. Springer, New York, pp 57115
-
Takata K, Fujikura K, Shin B-C 1997 Ultrastructure
of the rodent placental labyrinth: a site of barrier and transport. J
Reprod Develop 43:1324[CrossRef]
-
Jollie WP 1964 Fine structural changes in placental
labyrinth of the rat with increasing gestational age. J Ultrastruct Res 10:2747
-
Enders AC 1965 A comparative study of the fine
structure of the trophoblast in several hemochorial placentas. Am
J Anat 116:2968[CrossRef][Medline]
-
Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H 1990 Erythrocyte/HepG2-type glucose transporter is concentrated in
cells of blood-tissue barriers. Biochem Biophys Res Commun 173:6773[CrossRef][Medline]
-
Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H 1994 Immunolocalization of glucose transporter GLUT1 in the rat
placental barrier: possible role of GLUT1 and the gap junction in the
transport of glucose across the placental barrier. Cell Tissue Res 276:411418[Medline]
-
Forssmann WG, Metz J, Heinrich D 1975 Gap junctions
in the hemotrichorial placenta of the rat. J Ultrastruct Res 53:374381[CrossRef][Medline]
-
Metz J, Heinrich D, Forssmann WG 1976 Ultrastructure of the labyrinth in the rat full-term placenta. Anat
Embryol 149:123148[CrossRef][Medline]
-
Metz J, Heinrich D, Forssmann WG 1976 Gap junctions
in hemodichorial and hemotrichorial placentae. Cell Tissue Res 171:305315[CrossRef][Medline]
-
Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I,
Morris HR, Allard WJ, Lienhard GE, Lodish HF 1985 Sequence and
structure of a human glucose transporter. Science 229:941945[Abstract/Free Full Text]
-
Kasahara M, Inui K, Takano M, Hori R 1985 Distinction of three types of D-glucose transport systems in animal
cells. Biochem Biophys Res Commun 132:490496[CrossRef][Medline]
-
Nagamatsu S, Sawa H, Kamada K, Nakamichi Y, Yoshimoto K,
Hoshino T 1993 Neuron-specific glucose transporter (NSGT): CNS
distribution of GLUT3 rat glucose transporter (RGT3) in rat central
neurons. FEBS Lett 334:289295[CrossRef][Medline]
-
Van Bueren AM, Moholt-Siebert M, Begley DE, McCall
AL 1993 An immunization method for generation of high affinity
antisera against glucose transporters useful in immunohistochemistry.
Biochem Biophys Res Commun 197:14921498[CrossRef][Medline]
-
Inukai K, Katagiri H, Takata K, Asano T, Anai M,
Ishihara H, Nakazaki M, Kikuchi M, Yazaki Y, Oka Y 1995 Characterization of rat GLUT5 and functional analysis of chimeric
proteins of GLUT1 glucose transporter and GLUT5 fructose transporter.
Endocrinology 136:48504857[Abstract]
-
Sawada H, Esaki M 1994 Use of Nanogold followed by
silver enhancement and gold toning for preembedding immunolocalization
in osmium-fixed, Epon-embedded tissues. J Electron Microsc 43:361366[Abstract/Free Full Text]
-
Murata F, Tsuyama S, Ihida K, Kashio N, Kawano M, Li
ZZ 1992 Sulfated glycoconjugates demonstrated in combination with
high iron diamine thiocarbohydrazide-silver proteinate and silver
acetate physical development. J Electron Microsc 41:1420[Abstract/Free Full Text]
-
Gould GW, Thomas HM, Jess TJ, Bell GI 1991 Expression of human glucose transporters in Xenopus oocytes: kinetic
characterization and substrate specificities of the erythrocyte, liver,
and brain isoforms. Biochemistry 30:51395145[CrossRef][Medline]
-
Raviola G 1977 The structural basis of the
blood-ocular barriers. Exp Eye Res [Suppl] 25:2763
This article has been cited by other articles:

|
 |

|
 |
 
A. Ablimit, T. Aoki, T. Matsuzaki, T. Suzuki, H. Hagiwara, S. Takami, and K. Takata
Immunolocalization of Water Channel Aquaporins in the Vomeronasal Organ of the Rat: Expression of AQP4 in Neuronal Sensory Cells
Chem Senses,
June 1, 2008;
33(5):
481 - 488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ganguly, R. A. McKnight, S. Raychaudhuri, B.-C. Shin, Z. Ma, K. Moley, and S. U. Devaskar
Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction
Am J Physiol Endocrinol Metab,
May 1, 2007;
292(5):
E1241 - E1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Constancia, E. Angiolini, I. Sandovici, P. Smith, R. Smith, G. Kelsey, W. Dean, A. Ferguson-Smith, C. P. Sibley, W. Reik, et al.
Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems
PNAS,
December 27, 2005;
102(52):
19219 - 19224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pavek, F. Staud, Z. Fendrich, H. Sklenarova, A. Libra, M. Novotna, M. Kopecky, M. Nobilis, and V. Semecky
Examination of the Functional Activity of P-glycoprotein in the Rat Placental Barrier Using Rhodamine 123
J. Pharmacol. Exp. Ther.,
June 1, 2003;
305(3):
1239 - 1250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Thompson, V.K.M. Han, and K. Yang
Spatial and Temporal Patterns of Expression of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 Messenger RNA and Glucocorticoid Receptor Protein in the Murine Placenta and Uterus During Late Pregnancy
Biol Reprod,
December 1, 2002;
67(6):
1708 - 1718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. G. Das, J. He, R. A. Ehrhardt, W. W. Hay Jr., and S. U. Devaskar
Time-dependent physiological regulation of ovine placental GLUT-3 glucose transporter protein
Am J Physiol Regulatory Integrative Comp Physiol,
December 1, 2000;
279(6):
R2252 - R2261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sawada and M. Esaki
A Practical Technique to Postfix Nanogold-immunolabeled Specimens with Osmium and to Embed Them in Epon for Electron Microscopy
J. Histochem. Cytochem.,
April 1, 2000;
48(4):
493 - 498.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Kamei, O. Tsutsumi, A. Yamakawa, Y. Oka, Y. Taketani, and J. Imaki
Maternal Epidermal Growth Factor Deficiency Causes Fetal Hypoglycemia and Intrauterine Growth Retardation in Mice: Possible Involvement of Placental Glucose Transporter GLUT3 Expression
Endocrinology,
September 1, 1999;
140(9):
4236 - 4243.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H.-D. Gabriel, D. Jung, C. Butzler, A. Temme, O. Traub, E. Winterhager, and K. Willecke
Transplacental Uptake of Glucose Is Decreased in Embryonic Lethal Connexin26-deficient Mice
J. Cell Biol.,
March 23, 1998;
140(6):
1453 - 1461.
[Abstract]
[Full Text]
[PDF]
|
 |
|